Lexaria Bioscience (LEXX) Minority Interest (2014 - 2026)
Lexaria Bioscience's (LEXX) quarterly Minority Interest came in at -$392191.0 in Q1 2026, down 2.12% year-on-year from -$400697.7 in Q1 2025, and down 0.71% quarter-over-quarter from -$389438.0 in Q4 2025.
Lexaria Bioscience (LEXX) Minority Interest (2014 - 2026) Analysis & Trends
Lexaria Bioscience has disclosed Minority Interest across 12 years of filings, most recently posting -$392191.0 for Q1 2026.
- Minority Interest for Q1 2026 came in at -$392191.0, down 2.12% year-over-year; the trailing twelve-month figure through Feb 2026 was -$392191.0 (down 2.12% YoY), and the FY2025 annual result was -$386942.0, down 2.54% from the prior year.
- Minority Interest came in at -$392191.0 for Q1 2026 at Lexaria Bioscience, down from -$389438.0 in the prior quarter.
- In the past five years, Minority Interest ranged from a high of -$235307.0 in Q1 2022 to a low of -$392191.0 in Q1 2026.
- The 5-year median for Minority Interest is -$372949.0 (2024), against an average of -$354526.0.
- Across the five-year window, Minority Interest tumbled 249.26% in 2022 and declined 2.12% in 2026, its largest moves.
- Lexaria Bioscience's Minority Interest stood at -$329776.0 in 2022, then dropped by 12.12% to -$369755.0 in 2023, then fell by 2.85% to -$380278.0 in 2024, then retreated by 2.41% to -$389438.0 in 2025, then decreased by 0.71% to -$392191.0 in 2026.
- The last three Minority Interest figures came in at -$392191.0 (Q1 2026), -$389438.0 (Q4 2025), and -$386942.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Lexaria Bioscience | 7.17 Mn | 1.65 Mn | 20,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -392,191.00 |
| Nov 30, 2025 | -389,438.00 |
| Aug 31, 2025 | -386,942.00 |
| May 31, 2025 | -385,552.00 |
| Feb 28, 2025 | -384,038.00 |
| Nov 30, 2024 | -380,278.00 |
| Aug 31, 2024 | -377,349.00 |
| May 31, 2024 | -375,568.00 |
| Feb 29, 2024 | -372,949.00 |
| Nov 30, 2023 | -369,755.00 |
| Aug 31, 2023 | -364,040.00 |
| May 31, 2023 | -354,344.00 |
| Feb 28, 2023 | -342,283.00 |
| Nov 30, 2022 | -329,776.00 |
| Aug 31, 2022 | -316,414.00 |
| May 31, 2022 | -270,718.00 |
| Feb 28, 2022 | -235,307.00 |
| Nov 30, 2021 | -212,410.00 |
| Aug 31, 2021 | -202,085.00 |
| May 31, 2021 | -77,512.00 |